Robin Hough talks with his mother and a nurse practitioner about weight lost, side effects like nausea and hair loss, and how coverage can stop at goal weight.
Recap by typeshit. Full story at Healthline.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
8:25
The I looked into channel digs into the retatrutide trial data to ask how much of the weight lost on the triple agonist may come from muscle.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
Loading…